Clinical Trial Update: Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing secondary prophylaxis with recombinant Factor VIII to episodic treatment in adults/adolescents with severe Hemophilia A. Results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant Factor VIII (Factor VIII, recombinant)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2013-08-07